To criminalize fraudulent statements made with respect to clinical vaccine trials.
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
The bill adds or tightens a compliance mandate provision: 2. Medical research company or sponsor Chapter 47 of title 18, United States Code, is amended by adding at the end the following: Whoever, being a medical research, adds or tightens a compliance mandate provision: 1041. Clinical vaccine trial fraud Whoever, being a medical research company or sponsor, makes a fraudulent statement to, or conceals from, any department or agency, and reduces a appropriation, compliance mandate, liability shield provision: 7. It relies on compliance mandates, liability protections, and appropriations. The main policy areas are Environment and Healthcare.
Who Benefits and How
The available clause analysis does not identify a specific beneficiary group.
Who Bears the Burden and How
No clear private burden is identified from the available clause analysis; implementing agencies may still take on administrative work.
Key Provisions
- Adds or tightens a compliance mandate provision: 2. Medical research company or sponsor Chapter 47 of title 18, United States Code, is amended by adding at the end the following: Whoever, being a medical research...
- Adds or tightens a compliance mandate provision: 1041. Clinical vaccine trial fraud Whoever, being a medical research company or sponsor, makes a fraudulent statement to, or conceals from, any department or agency...
- Reduces a appropriation, compliance mandate, liability shield provision: 7.
- Requires loosens a compliance mandate, liability shield provision: 8.
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for primary purpose and policy domains.
At a Glance
What This Bill Does
The bill adds or tightens a compliance mandate provision: 2. Medical research company or sponsor Chapter 47 of title 18, United States Code, is amended by adding at the end the following: Whoever, being a medical research, adds or tightens a compliance mandate provision: 1041. Clinical vaccine trial fraud Whoever, being a medical research company or sponsor, makes a fraudulent statement to, or conceals from, any department or agency, and reduces a appropriation, compliance mandate, liability shield provision: 7.
Key Policy Areas
Environment, Healthcare
Primary Purpose
The bill adds or tightens a compliance mandate provision: 2. Medical research company or sponsor Chapter 47 of title 18, United States Code, is amended by adding at the end the following: Whoever, being a medical research, adds or tightens a compliance mandate provision: 1041. Clinical vaccine trial fraud Whoever, being a medical research company or sponsor, makes a fraudulent statement to, or conceals from, any department or agency, and reduces a appropriation, compliance mandate, liability shield provision: 7.
Policy Domains
Sponsors
Legislative Progress
IntroducedMr. Green of Tennessee introduced the following bill; which was …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "secretary_of_health_and_human_services"
- → Secretary of Health and Human Services
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology